ZENITHDRUG
Start SIP
Invest Now
Start SIP in ZENITHDRUG
Performance
- Low
- ₹45
- High
- ₹52
- 52 Week Low
- ₹45
- 52 Week High
- ₹107
- Open Price₹47
- Previous Close₹47
- Volume88,000
- 50 DMA₹50.77
- 100 DMA₹54.95
- 200 DMA₹61.47
Investment Returns
- Over 1 Month -4.85%
- Over 3 Month -18.97%
- Over 6 Month -25.27%
- Over 1 Year -37.8%
Smart Investing Starts Here Start SIP with Zenith Drugs for Steady Growth!
Zenith Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 11.5
- PEG Ratio
- -
- Market Cap Cr
- 82
- P/B Ratio
- 1.1
- Average True Range
- 2.82
- EPS
- 4.26
- Dividend Yield
- 0
- MACD Signal
- -0.7
- RSI
- 46.96
- MFI
- 61.62
Zenith Drugs Financials
Zenith Drugs Technicals
EMA & SMA
Current Price
₹48.05
+
1.25
(2.67%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹48.67
- 50 Day
- ₹50.77
- 100 Day
- ₹54.95
- 200 Day
- ₹61.47
Resistance and Support
48.27
- R3 57.83
- R2 54.72
- R1 51.38
- S1 44.93
- S2 41.82
- S3 38.48
Zenith Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results & Others | To consider Other business matters. Final Dividend of Re. 0.5 per equity share |
| 2025-05-29 | Audited Results & Others | To consider Other business matters. Final Dividend of Re. 0.5 per equity share |
| 2025-04-17 | To consider Fund Raising & Others | To consider Other business matters. (Revised) Final Dividend of Re. 0.5 per equity share |
| 2024-11-14 | Quarterly Results | |
| 2024-05-29 | Audited Results |
Zenith Drugs F&O
About Zenith Drugs
- NSE Symbol
- ZENITHDRUG
- BSE Symbol
- Managing Director
- Mr. Sandeep Bhardwaj
- ISIN
- INE0QWN01013
Similar Stocks to Zenith Drugs
Zenith Drugs FAQs
Zenith Drugs share price is ₹48 As on 17 February, 2026 | 23:54
The Market Cap of Zenith Drugs is ₹82.4 Cr As on 17 February, 2026 | 23:54
The P/E ratio of Zenith Drugs is 11.5 As on 17 February, 2026 | 23:54
The PB ratio of Zenith Drugs is 1.1 As on 17 February, 2026 | 23:54
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.